INTRODUCTION
Cleft lip and palate is one of the most common birth defects. The frequency of cleft lip and palate in Japanese people is about 1 in 500, which is higher than in Caucasian and Black races. Epidemiological studies suggest that exogenous factors and genetic factors play a role in the aetiology of cleft lip and palate, but its aetiology and pathogenesis remain obscure.
The mammalian palate begins to develop from projections of the paired maxillary processes of the first branchial arches, termed the palatal shelves (or lateral palatine processes) [1] . Initially, these shelves are in a vertical position on each side of the developing tongue, but, as the mandible grows, the tongue moves downward, and the shelves become horizontal and grow towards each other. Subsequently, the shelves grow sufficiently large to contact one another and begin to fuse. During fusion, the apposed epithelia form an epithelial seam, which undergoes apoptosis, migration and\or transformation, and results in mesenchymal continuity. Thus palate formation is complex, and there are numerous potential untoward possibilities, the most common being delayed shelf horizontalization and inadequate shelf growth [2, 3] .
Transforming growth factor α (TGFα) is a secretory protein that binds to the epidermal growth factor (EGF) receptor, which has been localized to the palatal epithelium during palatal closure [4] . TGFα may function as a normal embryonic version of EGF-related growth factor [5] . Sandgren et al. [6] reported that TGFα is a potent epithelial mitogen, based on observations that epithelium hyperplasia was seen in many tissues of transgenic mice with excessive TGFα production. The TGFβ gene family has biological activities that control cell proliferation, migration and differentiation, regulation of extracellular matrix deposition and epithelial\ mesenchymal transformation. Immunohistochemical and in situ hybridization analyses have demonstrated high expression of TGFβ1, TGFβ2 and TGFβ3 during the development of palatal tissue [7] [8] [9] [10] . In addition, transgenic mice lacking TGFβ2 or TGFβ3 in vivo develop a cleft palate [11] [12] [13] . Polymorphisms of TGFβ genes have been reported, and may play a role in disease phenotypes [9] . Furthermore, teratological and genetic studies have implicated γ-aminobutyric acid (GABA) in mouse craniofacial development [14] . Culiat et al. [15] reported the necessity of the GABA type A receptor β3 (GABRB3) gene for normal development of the palate. Subsequent studies [16] [17] [18] demonstrated that GABRB3-knockout mice showed the phenotype of a cleft palate, which was rescued by the GABRB3 gene.
Aetiological studies [19, 20] have shown that cases of non-syndromic cleft palate are associated with allelic variations of TGFα. In contrast, a failure to observe an association of TGFα with non-syndromic cleft lip and cleft palate has been reported [21, 22] . Furthermore, the association of the expression and allelic variations of TGFβ1, TGFβ2, TGFβ3 and GABRB3 with non-pathological cleft lip and palate has not been reported. To define further the involvement of genes that affect clefting aetiology, we investigated genetic variations of candidate gene loci, including the TGFα gene (chromosome 2p11-13) [23] , the TGFβ2 gene (chromosome 1q41) [24, 25] , the TGFβ3 gene (chromosome 14q24) [26] and the GABRB3 gene (chromosome 15q) [14, 27] , in a group of unrelated Japanese individuals with cleft lip and palate. We report here that certain alleles of TGFα and TGFβ2 variants are associated with the manifestation of cleft lip and palate.
MATERIALS AND METHODS

Populations of patients and controls
The study subjects were all Japanese. The study was approved by the local ethical committee, and all subjects gave informed consent. Blood samples were collected from the patient and control groups. The patient group contained subjects with cleft lip (with or without cleft palate) or cleft palate only ; subjects with chromosomal disorders, known teratogenic exposure and other recognized syndromes, as well as children with other structural anomalies and\or developmental delay, were excluded. Cases ranged in age from 0 years to 37 years, and were recruited through the Kansai Medical University Hospital, the Saiseikai Nakatsu Hospital or the Hikone City Hospital. Subjects who had no craniofacial anomaly or other congenital disease and no family history of craniofacial anomaly were used as controls. The controls were healthy volunteers ranging in age from 15 years to 60 years, and were recruited through the Kansai Medical University Hospital.
Molecular analysis
DNA was extracted from whole blood using a DNA preparation kit (BIO101 Inc., Vista, CA, U.S.A.). DNA samples were dissolved in 10 mM Tris\HCl, pH 7.5, containing 1 mM EDTA and stored at k20 mC.
The primer pairs for each of the TGFα, TGFβ2, TGFβ3 and GABRB3 genes were synthesized to amplify regions of the corresponding genes, and the conditions of PCR for the indicated DNA fragments are shown in Table 1 . For analysis of the TGFα K-primer region, the amplified DNA fragment was screened by digestion with the restriction enzymes HinfI and NcoI and by direct sequencing, using the method of Shiang et al. [20] . As shown in Figure 1 (A), alleles 1 and 2 of the TGFα Kprimer region can be cut with NcoI (C\CATG), but not with HinfI. Allele 1 was distinguished from allele 2 by DNA sequencing. While no site digested with NcoI or HinfI was present in allele 3, allele 4 of the TGFα Kprimer region can be cut with NcoI and HinfI. After treatment of the fragment with restriction enzymes, DNA samples were analysed by electrophoresis using a 1% (w\v) agarose gel.
Amplified DNA fragments of the TGFα P-primer region ( Figure 1B) were screened by single-strand conformation polymorphism (SSCP) analysis and by direct sequencing [20] .
The TaqI-primer region of TGFα has two different types of polymorphism [28] , whereby the sequences either contain a restriction site for TaqI (allele 2), due to insertion of TAAT, or lack this site (allele 1) ( Figure 1C ). The amplified DNA fragments of the TaqI-primer region of the TGFα gene were then digested with TaqI at 65 mC for 2 h, and the digested DNAs were electrophoresed with a 2 % NuSieve\agarose (3 : 1, w\w) gel (FMC Bioproducts, Rockland, ME, U.S.A.).
The TGFβ2 gene has an ACA repeat sequence in its 3h-non-coding region, and polymorphism is dependent on differences in ACA repeats [24] . The DNA sequence variants of the amplified DNA fragments of TGFβ2 were examined by SSCP analysis, and the number of ACA repeats was confirmed by DNA sequencing. Alleles 1, 2 and 3 of the gene contain seven, eight and nine ACA repeats respectively.
The TGFβ3 gene has a CA repeat sequence [22] , and polymorphism is dependent on the frequency of CA repeats. DNA sequence variants of the amplified DNA fragments of the TGFβ3 gene were analysed by denaturing PAGE (5 % gels).
Polymorphism of the GABRB3 gene depends on differences in CA repeats [14] . Amplified fragments of the GABRB3 gene were screened for DNA sequence variants by SSCP analysis.
Statistical analysis
In statistical examination, χ# analysis was performed at the significance level of P 0.05, which was accounted for using the Bonferroni correction.
RESULTS
Classification of groups of cleft lip and palate
Based on the mechanisms of development of the lip and the palate, previous observations [29] [30] [31] showed that cleft lip occurs by a similar mechanism to cleft lip and palate, which develops by a different mechanism from Analyses were performed separately for cleft lip (with or without cleft palate) and cleft palate only, but we did not analyse the statistical significance of genetic variants for the cleft palate group, since the number of blood samples collected from this group was small (n l 4).
Association of TGFα gene variants with cleft lip (with or without cleft palate)
To examine the variants of the TGFα gene in patients and controls, the PCR products of the TGFα K-primer region were first analysed by use of restriction enzymes (NcoI and HinfI) and by direct sequencing. Figure 2(A) shows the analysis of allelic variants of the TGFα Kprimer region. Fragments of alleles 1, 2, and 4 of the Gene variants associated with cleft lip and palate K-primer region can be cut with NcoI (C\CATGG), whereas only the allele 4 fragment of the K-primer region can be cut with HinfI (G\ANTC). Direct sequencing was performed for groups which could not be distinguished on the basis of digestion with restriction enzymes (alleles 1 and 2). No restriction site for HinfI or NcoI was present in allele 3. From the results of this analysis, allele 4 was the most common among the cases of cleft lip (with or without cleft palate), whereas allele 2 was the most common among controls. A highly significant difference was observed in cases of cleft lip (with or without cleft palate) and controls ( χ# l 10.190 ; P l 0.017) ( Table 2) .
The PCR products of the P-primer region were next analysed by SSCP, and the differences were confirmed by direct sequencing. Two different alleles of the TGFα Pprimer region are shown in Figure 1(B) . In both patient and control groups, the frequency of allele 1 in the TGFα P-primer region was 3-4 times greater than that of allele 2 ( Table 2 ). There was no significant difference in allele frequencies in the TGFα P-primer region between cases and controls ( χ# l 1.623 ; P l 0.203).
The PCR products of the TaqI-primer region of the TGFα gene were then analysed by digestion with TaqI. As shown in Figure 2 (B), the variant allele 2 was digested with TaqI, but allele 1 was not. In the 104 subjects analysed, a heterozygote of alleles 1 and 2 (lane 1) and a homozygote of allele 1 (lane 2) were found. Allele 1 was predominant in both patient and control groups. No significant difference was observed between cases of cleft lip (with or without cleft palate) and controls ( χ# l 0.028 ; P l 0.866) ( Table 2) .
Analysis of TGFβ genes in patients with cleft lip (with or without cleft palate)
We next examined variations in the PCR products of the TGFβ2 gene by SSCP. Figure 3 shows SSCP analysis of the variation in the number of ACA repeats in the TGFβ2 primer region. There were three different alleles in the case and control groups under the conditions used. Allele 2 of the TGFβ2 gene, corresponding to eight ACA repeats, was most common in both the patient and control groups, and the proportion of allele 2 in the case group was greater than in the control group (Table 2) . There was a significant difference in the proportion of allele 2 between cases of cleft lip (with or without cleft palate) and controls ( χ# l 19.208 ; P 0.0001). In addition, the frequency of cases of cleft lip (with or without cleft palate) carrying allele 2 of the TGF β2 gene plus allele 4 of the K-primer region of the TGFα gene was much higher than in the control group (P l 0.0117).
The PCR products of the TGFβ3 primer region were analysed by SSCP and denaturing PAGE (results not shown). Lidral et al. [22] found three types of alleles of the TGFβ3 gene : the product of allele 1 was 166 bp in size, that of allele 2 was 168 bp and that of allele 3 was 170 bp. In the present study, we recognized two variations (alleles 1 and 2) of the TGFβ3 gene in Japanese people. In both groups, allele 1 of TGFβ3 was present in greater amounts than allele 2, and χ# analysis of TGFβ3 variants between cases and controls showed no significant difference (P l 0.520) ( Table 2) .
No association of GABRB3 gene variants with cleft lip (with or without cleft palate)
Finally, the PCR products of the GABRB3 gene were analysed by SSCP. A total of 28 types of allele variants of the GABRB3 primer region, derived from differences in the number of CA repeats, were found, and statistical analysis of GABRB3 polymorphism was difficult due to these variations. However, no CA repeat variant was significantly more frequent in the patient group than among controls.
DISCUSSION
The prevalence of cleft lip and palate in humans is between 1 in 500 and 1 in 2000. Clinically it causes problems of ingestion, swallowing, dysarthria, occlusal disharmony, hypoplasia of the maxilla during growth and external appearance to differing degrees. Corrective surgery, orthodontic treatment and speech exercises are required to effect improvement. The burden on patients and their families is therefore heavy. In the present study, we selected as candidate genes members of the TGF family (TGFα, TGFβ2, and TGFβ3), for which local occurrence in the developmental stage of the palate has been demonstrated in studies on rodents [4, [11] [12] [13] , and the GABRB3 gene, which has been suggested to be involved in craniofacial development as a GABA receptor [16] [17] [18] .
We found that there were significant differences in the polymorphism of the TGFα gene K-primer region and of the TGFβ2 gene between the patient group and a control group. These differences were not ascribed for mutations in these genes causing orofacial cleft, since the frequencies determined for these variant alleles permits the prediction of a Hardy-Weinberg equilibrium at each individual locus (results not shown). No significant differences were observed between the case and control groups in the polymorphism of the TGFα gene P-primer region, the TaqI-primer region of the TGFβ3 gene, or the GABRB3 gene. The present results indicate that the TGFα gene (Kprimer region) and TGFβ2 gene may be involved in the manifestation of cleft lip and palate in Japanese populations.
Several aetiological studies of cleft lip and palate have been performed to date. Ardinger et al. [19] reported that, in Caucasian patients having cleft lip with or without cleft palate, there was a significant difference in the TGFα TaqI region between the patient group and a control group. Jara et al. [34] performed association studies between controls and patients with cleft lip and cleft palate in South America, and found a significant difference in the TGFα BamHI region. On the other hand, Shiang et al. [20] reported that significant differences were found (P l 0.02) in the TGFα TaqI region and Kprimer region when cleft palate only was designated as a case group of the American population, but no significant difference in the P-primer region of the TGFα gene was observed. Hecht et al. [35] failed to find an association with TGFα polymorphisms in a small number of cleft lip\palate groups (n l 7). Hwang et al. [28] reported that no significant difference was found compared with controls (P l 0.51) in the TGFα TaqI region when cleft lip with or without cleft palate was designated as a case group. Like ours, their study was also performed with patients having cleft lip with or without cleft palate being employed as a case group ; in addition, statistics were also taken separately from patients with cleft palate only, but no significant differences were found. Lidral et al. [22] reported no significant differences between patient and control groups with regard to TGFα, TGFβ2 and TGFβ3 genes in the Philippines. Although there were some variations in selection of cases, control and statistical procedures among the various studies that may explain these different results, it should be noted that TGFα is one of several genes that affect palate development, and the influence of other genes may be dominant in some populations.
In a Japanese population, we found significant differences in TGFα K-primer region and TGFβ2 polymorphism between a patient group with non-syndromic cleft lip (with or without cleft palate) and a control group. The TGFα K-primer region was identified with the 3h-non-coding region of TGFα mRNA. The ACA repeat of the TGFβ2 gene is also located in the 3h-non-coding region of TGFβ2 mRNA. The functions of differences in the expression of the TGFα and TGFβ2 variants are unclear, but it is possible that the different sequences may contribute to the stabilities of TGFα and TGFβ2 mRNAs.
TGFα, which was thought to be a candidate gene related to cleft lip with or without cleft palate, is highly expressed on the palate epithelium during the embryonic stage, and seems to be involved in adhesion [19, 20, 34] . However, TGFα knockout mice did not yield a phenotype with cleft palate [36] . Development may be different between mice and humans with regard to a defect of TGFα, but is reasonable to conclude from the results of our experiments that variations in TGFα expression may alter sensitivity to other environmental factors, thereby leading to development of cleft lip with or without cleft palate. In addition, if one of the TGFβ isoforms (including TGFβ1, TGFβ2 and TGFβ3) is absent, other isoforms can compensate for their activity to some extent [8, 9] , but it is impossible to compensate for all activities. Therefore we propose that interactions between certain variations of TGFβ2 and other factors may trigger the development of cleft lip and palate in humans. Although we examined genetic variations of GABRB3, another factor that may be involved in clefting defects [16] [17] [18] , both the patient group and the control group showed more than 20 types of polymorphism of the gene, which were similarly distributed. Thus we obtained no evidence that GABRB3 is involved in these defects in our population, as no actual statistics were performed.
It is known that drugs, chemical substances, physical factors, environmental factors, infections and hereditary factors may be involved in the development of cleft lip and palate [3] . Furthermore, multiple hereditary factors complicated by other environmental factors may also cause sensitivity in individuals. We cannot exclude the possibility that other, as yet unidentified, polymorphisms in the TGFα and TGFβ genes are associated with orofacial cleft defects, since we analysed these genes in a relatively small case group (n l 43). However, the present data indeed show that polymorphisms of the TGFα and TGFβ2 genes are associated with the development of cleft lip and palate in humans, and suggest that allele 1 of the TGFα K-primer region as well as that of the TGFβ2 gene increase the likelihood of a subject developing cleft lip and palate. Therefore the involvement of environmental factors in addition to the sensitivity conferred by genetic factors should be considered. We hope that the results of the present study will help to clarify the aetiology, gene diagnosis and gene therapy of oral clefts in the future.
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